INVO Fertility Registers Up to 20M Shares for $15M–$50M Dilutive Equity Line with Alumni Capital
IVF is trading near its 52-week low of $1 (4.0% above the low).
Summary
INVO Fertility registered up to 20 million shares for resale by Alumni Capital under a $15M–$50M equity line announced today. The shares, if fully issued, would dilute existing holders by nearly 90%, with Alumni able to buy at discounts as low as 85% of market and immediately resell.
Key Events · Financing and Capital Events · IVF
-
Equity Line Registration
An S-1 registers the resale of up to 20 million shares by Alumni Capital LP under a $15M–$50M equity line. Against the 2.3 million shares outstanding, this represents roughly 90% dilution.
-
Deep Discount Pricing
Alumni can purchase shares at 94% of the lowest 5-day VWAP, 97% of the lowest prior-day trade, or 85% of the lowest 5-day trade—pricing that heavily discounts the already-depressed $1.04 stock.
-
Immediate Resale Overhang
Because Alumni is deemed an underwriter, it can resell shares immediately after purchase, creating constant selling pressure on the stock.
-
Commitment Fee
A 1% commitment fee ($150K–$500K), payable in cash or stock, adds to the cost of the facility for INVO.
Analysis · IVF · Industrial Applications And Services
INVO Fertility filed an S-1 to register the resale of up to 20 million shares underlying a newly signed equity line with Alumni Capital LP. The deal allows the company to sell up to $15 million (expandable to $50 million) of stock to Alumni at a discount to market, with Alumni then reselling into the open market. The registration makes these shares freely tradable, creating a significant overhang. With only 2.3 million shares outstanding, the 20 million registered shares represent potential dilution of nearly 90%. The pricing mechanics—as low as 85% of the lowest recent trading price—signal deep discounting. This comes against a backdrop of a going-concern warning, restated financials, and a stock trading near its 52-week low of $1.00. The equity line provides a lifeline but at a steep cost to existing shareholders.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.1% of the 372 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IVF was trading at $1.04 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $1.00 to $102.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.